| Authors: |
Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Derosa L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Valdelièvre C; Department of Surgery, Institut Curie, Paris, France., Yonekura S; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Opolon P; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Priour M; Informatics Department, Institut Curie, Paris, France., Guerin J; Informatics Department, Institut Curie, Paris, France., Pierga JY; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Asselain B; Biostatistics Department, Institut Curie, Paris, France., De Croze D; Tumor Biology, Institut Curie, Paris, France., Pinheiro A; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France., Lae M; Tumor Biology, Institut Curie, Paris, France., Talagrand LS; Department of Surgery, Institut Curie, Paris, France., Laas E; Department of Surgery, Institut Curie, Paris, France., Darrigues L; Department of Surgery, Institut Curie, Paris, France., Grandal B; Department of Surgery, Institut Curie, Paris, France., Marangoni E; Preclinical investigation laboratory, Translational Research Department, Institut Curie, PSL Research University, Paris., Montaudon E; Preclinical investigation laboratory, Translational Research Department, Institut Curie, PSL Research University, Paris., Kroemer G; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.; Cell Biology and Metabolomics platforms, Villejuif, France.; INSERM, Paris, France.; Sorbonne Paris Cité, Université Paris Descartes, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden., Zitvogel L; Gustave Roussy Cancer Campus (GRCC), Villejuif, France.; Institut National de la Santé Et de la Recherche Medicale (INSERM), Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.; Univ. Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Gustave Roussy and Institut Curie, France., Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, U932, Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.; Department of Surgery, Institut Curie, Paris, France.; Sorbonne Paris Cité, Université Paris Descartes, Paris, France. |
